pharma is the sole category represented across all 1 tracked stories. DRW Securities LLC is most often covered alongside Adage Capital Partners GP L.L.C., which appears in 1 of these 1 story. The tracked stories average 2 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about DRW Securities LLC
pharma is the sole category represented across all 1 tracked stories. DRW Securities LLC is most often covered alongside Adage Capital Partners GP L.L.C., which appears in 1 of these 1 story. The tracked stories average 2 original sources each. DRW Securities LLC appears in 1 tracked Biotech story from August 13, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering DRW Securities LLC. Shared-story counts are live from our verified record — not editorial picks.
SCYNEXIS shorts collapsed 87.6% to 320,181 shares, signaling bear exhaustion, while Ensysce Biosciences short interest exploded 619.9% to 364,278. Focus Universal also saw a 282.8% build, reflecting a stark divergence in microcap biotech sentiment.